Riskpilot← Back to searchSign inGet full accessGYN MEB AS
ASActiveOrg 912637956Skåregata 92, 5528 HaugesundMedical specialists activities · NACE 8622Est. 20135 employees
Revenue 2024
NOK 5,8M
+10% vs 2023
EBITDA margin
38.6%
+37% vs 2023
Equity ratio
43.7%
Financial strength
Net profit 2024
NOK 1,6M
+43% vs 2023
| Revenue | NOK 5,8M | +10% |
| EBITDA | NOK 2,3M | +37% |
| Net profit | NOK 1,6M | +43% |
| Total assets | NOK 1,5M | -2% |
| Equity | NOK 642K | +1264% |
| Employees | 5 | — |
Legal name
GYN MEB AS
Org number
912637956
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
26. oktober 2013
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Spesialistlegetjenester innen gynekologi og andre beslektede medisinske fagfelt, herunder også deltakelse i andre selskaper innenfor samme virksomhetsområde.
Address
Skåregata 92, 5528 Haugesund
Phone
+4570202728
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 4 393 | 4 421 | 4 506 | 4 631 | 4 395 | 4 738 | 4 946 | 5 291 | 5 828 |
| Staff expenses | −0 | −0 | −0 | −3 040 | −2 754 | −1 949 | −2 174 | −2 026 | −1 714 | −2 080 | −1 959 | −1 959 |
| EBITDA | −13 | −10 | −16 | 53 | 534 | 1 501 | 1 406 | 1 342 | 1 730 | 1 537 | 1 645 | 2 252 |
| Depreciation & amort. | −0 | −0 | −0 | −24 | −249 | −217 | −211 | −211 | −203 | −193 | −219 | −219 |
| EBIT | −13 | −10 | −16 | 29 | 285 | 1 284 | 1 195 | 1 131 | 1 527 | 1 344 | 1 426 | 2 033 |
| Net financials | 0 | −48 | −54 | −56 | −79 | −16 | −1 | 2 | −0 | 1 | 5 | 12 |
| Profit before tax | −13 | −58 | −70 | −27 | 206 | 1 268 | 1 194 | 1 134 | 1 526 | 1 345 | 1 430 | 2 045 |
| Tax | −0 | −19 | −16 | −149 | 25 | 289 | 263 | 249 | 338 | 298 | 315 | 450 |
| Net profit | −13 | −39 | −54 | 122 | 181 | 979 | 931 | 884 | 1 188 | 1 048 | 1 116 | 1 595 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 22 | 788 | 1 031 | 2 773 | 2 522 | 2 176 | 1 980 | 1 663 | 1 597 | 1 516 | 1 494 | 1 470 |
| Equity | 17 | −22 | −76 | 30 | 212 | 31 | 262 | 1 146 | 734 | 181 | 47 | 642 |
| Long-term debt | 0 | 760 | 1 000 | 1 861 | 525 | 61 | 74 | 74 | 67 | 55 | 31 | 7 |
| Short-term debt | 6 | 50 | 107 | 882 | 1 786 | 2 084 | 1 644 | 443 | 797 | 1 280 | 1 416 | 821 |
| Total debt | 6 | 810 | 1 107 | 2 743 | 2 311 | 2 145 | 1 718 | 517 | 864 | 1 335 | 1 447 | 828 |
EBITDA margin
38.6%
This company
15.8%
Market median
+144% vs market
20132024
Equity ratio
43.7%
This company
38.2%
Market median
+14% vs market
20132024
Return on equity
248.4%
This company
18.4%
Market median
+1250% vs market
20132024
Net profit margin
27.4%
This company
8.1%
Market median
+238% vs market
20132024
Asset turnover
3.96×
This company
1.12×
Market median
+254% vs market
20132024
Debt / equity
1.29×
This company
0.62×
Market median
-108% vs market
20132024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-09-27 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ME Chief Executive Officer | Chief Executive Officer | 2013 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2018 | — | — | |
| Chairman | 2018 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
GYN MEB AS 
GYNEKOLOGENE PÅ HAUGALANDET ASBoard members of GYN MEB AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maren Elisabeth Baumann | Chief Executive Officer | 0 companies |
| Lars Erik Niklas Smith | Board of Directors | 0 companies |
| Karl Christian Baumann | Chairman | 0 companies |